Skip to main content
Erschienen in: Der Anaesthesist 10/2007

01.10.2007 | CME Weiterbildung • Zertifizierte Fortbildung

Blutungen während der Schwangerschaft

verfasst von: Dr. S. Hofer, R. Schreckenberger, B. Heindl, K. Görlinger, H. Lier, H. Maul, E. Martin, M.A. Weigand

Erschienen in: Die Anaesthesiologie | Ausgabe 10/2007

Einloggen, um Zugang zu erhalten

Zusammenfassung

Blutungen während der Schwangerschaft sind oft fulminant und für Mutter und Kind vital bedrohlich. Sie sind für etwa 25% aller peripartalen maternen Sterbefälle verantwortlich. Die besondere Pathophysiologie der schwangerschaftsbedingten hämostaseologischen Veränderungen, wie das erhöhte Gerinnungspotenzial, eine verminderte antikoagulatorische Aktivität und starke Alterationen des fibrinolytischen Systems, müssen dem Behandlungsteam bekannt sein, um eine zielgerichtete, konsequente und interdisziplinäre Therapie durchführen zu können. Zu den wichtigsten therapeutischen Eckpfeilern bei peripartalen Blutungen zählen neben der kausalen gynäkologischen Therapie die frühzeitige Detektion und Durchbrechung einer Hyperfibrinolyse, die Optimierung von Fibrinogen und Thrombozyten als Endstrecke der Gerinnung und die Kenntnis der Möglichkeiten einer erweiterten Gerinnungstherapie.
Literatur
1.
Zurück zum Zitat Ananth CV, Savitz DA (1994) Vaginal bleeding and adverse reproductive outcomes: a meta-analysis. Paediatr Perinat Epidemiol 8: 62–78PubMedCrossRef Ananth CV, Savitz DA (1994) Vaginal bleeding and adverse reproductive outcomes: a meta-analysis. Paediatr Perinat Epidemiol 8: 62–78PubMedCrossRef
2.
Zurück zum Zitat Astermark J, Donfield SM, DiMichele DM et al. (2007) A randomized comparison of bypassing agents in hemophilia complicated by an inhibitor: the FEIBA NovoSeven Comparative (FENOC) Study. Blood 109: 546–551PubMedCrossRef Astermark J, Donfield SM, DiMichele DM et al. (2007) A randomized comparison of bypassing agents in hemophilia complicated by an inhibitor: the FEIBA NovoSeven Comparative (FENOC) Study. Blood 109: 546–551PubMedCrossRef
3.
Zurück zum Zitat Axelsen SM, Henriksen TB, Hedegaard M et al. (1995) Characteristics of vaginal bleeding during pregnancy. Eur J Obstet Gynecol Reprod Biol 63: 131–134PubMedCrossRef Axelsen SM, Henriksen TB, Hedegaard M et al. (1995) Characteristics of vaginal bleeding during pregnancy. Eur J Obstet Gynecol Reprod Biol 63: 131–134PubMedCrossRef
4.
Zurück zum Zitat Biron-Andreani C, Morau E, Schved JF et al. (2003) Amniotic fluid embolism with haemostasis complications: primary fibrinogenolysis or disseminated intravascular coagulation? Pathophysiol Haemost Thromb 33: 170–171PubMedCrossRef Biron-Andreani C, Morau E, Schved JF et al. (2003) Amniotic fluid embolism with haemostasis complications: primary fibrinogenolysis or disseminated intravascular coagulation? Pathophysiol Haemost Thromb 33: 170–171PubMedCrossRef
5.
Zurück zum Zitat Bonn C, Wetzka B, Zahradnik HP (2002) The use of TEG with the roTEG in preeclampsia and HELLP syndrome. Hypertens Pregnancy [Suppl 1] 21: 80 Bonn C, Wetzka B, Zahradnik HP (2002) The use of TEG with the roTEG in preeclampsia and HELLP syndrome. Hypertens Pregnancy [Suppl 1] 21: 80
6.
Zurück zum Zitat Bremme KA (2003) Haemostatic changes in pregnancy. Best Pract Res Clin Haematol 16: 153–168PubMedCrossRef Bremme KA (2003) Haemostatic changes in pregnancy. Best Pract Res Clin Haematol 16: 153–168PubMedCrossRef
7.
Zurück zum Zitat Catena C, Zingaro L, Casaccio D et al. (2000) Abnormalities of coagulation in hypertensive patients with reduced creatinine clearance. Am J Med 109: 556–561PubMedCrossRef Catena C, Zingaro L, Casaccio D et al. (2000) Abnormalities of coagulation in hypertensive patients with reduced creatinine clearance. Am J Med 109: 556–561PubMedCrossRef
8.
Zurück zum Zitat Charbit B, Mandelbrot L, Samain E et al. (2007) The decrease of fibrinogen is an early predictor of the severity of postpartum hemorrhage. J Thromb Haemost 5: 266–273PubMedCrossRef Charbit B, Mandelbrot L, Samain E et al. (2007) The decrease of fibrinogen is an early predictor of the severity of postpartum hemorrhage. J Thromb Haemost 5: 266–273PubMedCrossRef
9.
Zurück zum Zitat Chowdhury P, Saayman AG, Paulus U et al. (2004) Efficacy of standard dose and 30 ml/kg fresh frozen plasma in correcting laboratory parameters of haemostasis in critically ill patients. Br J Haematol 125: 69–73PubMedCrossRef Chowdhury P, Saayman AG, Paulus U et al. (2004) Efficacy of standard dose and 30 ml/kg fresh frozen plasma in correcting laboratory parameters of haemostasis in critically ill patients. Br J Haematol 125: 69–73PubMedCrossRef
10.
Zurück zum Zitat Clenney TL, Viera AJ (2004) Corticosteroids for HELLP (haemolysis, elevated liver enzymes, low platelets) syndrome. BMJ 329: 270–272PubMedCrossRef Clenney TL, Viera AJ (2004) Corticosteroids for HELLP (haemolysis, elevated liver enzymes, low platelets) syndrome. BMJ 329: 270–272PubMedCrossRef
11.
Zurück zum Zitat Collins PW (2003) Management of acquired haemophilia A – more questions than answers. Blood Coagul Fibrinolysis [Suppl 1] 14: S23–S27 Collins PW (2003) Management of acquired haemophilia A – more questions than answers. Blood Coagul Fibrinolysis [Suppl 1] 14: S23–S27
12.
Zurück zum Zitat Crochetiere C (2003) Obstetric emergencies. Anesthesiol Clin North Am 21: 111–125CrossRef Crochetiere C (2003) Obstetric emergencies. Anesthesiol Clin North Am 21: 111–125CrossRef
13.
Zurück zum Zitat Deneux-Tharaux C, Carmona E, Bouvier-Colle MH et al. (2006) Postpartum maternal mortality and cesarean delivery. Obstet Gynecol 108: 541–548PubMed Deneux-Tharaux C, Carmona E, Bouvier-Colle MH et al. (2006) Postpartum maternal mortality and cesarean delivery. Obstet Gynecol 108: 541–548PubMed
14.
Zurück zum Zitat Dildy GA (2002) Postpartum hemorrhage: new management options. Clin Obstet Gynecol 45: 330–344PubMedCrossRef Dildy GA (2002) Postpartum hemorrhage: new management options. Clin Obstet Gynecol 45: 330–344PubMedCrossRef
15.
Zurück zum Zitat Eder AF, Herron R, Strupp A et al. (2007) Transfusion-related acute lung injury surveillance (2003–2005) and the potential impact of the selective use of plasma from male donors in the American Red Cross. Transfusion 47: 599–607PubMedCrossRef Eder AF, Herron R, Strupp A et al. (2007) Transfusion-related acute lung injury surveillance (2003–2005) and the potential impact of the selective use of plasma from male donors in the American Red Cross. Transfusion 47: 599–607PubMedCrossRef
16.
Zurück zum Zitat FitzGerald MP, Floro C, Siegel J et al. (1996) Laboratory findings in hypertensive disorders of pregnancy. J Natl Med Assoc 88: 794–798PubMed FitzGerald MP, Floro C, Siegel J et al. (1996) Laboratory findings in hypertensive disorders of pregnancy. J Natl Med Assoc 88: 794–798PubMed
17.
Zurück zum Zitat Fonseca JE, Mendez F, Catano C et al. (2005) Dexamethasone treatment does not improve the outcome of women with HELLP syndrome: a double-blind, placebo-controlled, randomized clinical trial. Am J Obstet Gynecol 193: 1591–1598PubMedCrossRef Fonseca JE, Mendez F, Catano C et al. (2005) Dexamethasone treatment does not improve the outcome of women with HELLP syndrome: a double-blind, placebo-controlled, randomized clinical trial. Am J Obstet Gynecol 193: 1591–1598PubMedCrossRef
18.
19.
Zurück zum Zitat Franchini M, Lippi G, Franchi M (2007) The use of recombinant activated factor VII in obstetric and gynaecological haemorrhage. BJOG 114: 8–15PubMedCrossRef Franchini M, Lippi G, Franchi M (2007) The use of recombinant activated factor VII in obstetric and gynaecological haemorrhage. BJOG 114: 8–15PubMedCrossRef
20.
Zurück zum Zitat Fuchs AR, Romero R, Keefe D et al. (1991) Oxytocin secretion and human parturition: pulse frequency and duration increase during spontaneous labor in women. Am J Obstet Gynecol 165: 1515–1523PubMed Fuchs AR, Romero R, Keefe D et al. (1991) Oxytocin secretion and human parturition: pulse frequency and duration increase during spontaneous labor in women. Am J Obstet Gynecol 165: 1515–1523PubMed
21.
Zurück zum Zitat Gai MY, Wu LF, Su QF et al. (2004) Clinical observation of blood loss reduced by tranexamic acid during and after caesarian section: a multi-center, randomized trial. Eur J Obstet Gynecol Reprod Biol 112: 154–157PubMedCrossRef Gai MY, Wu LF, Su QF et al. (2004) Clinical observation of blood loss reduced by tranexamic acid during and after caesarian section: a multi-center, randomized trial. Eur J Obstet Gynecol Reprod Biol 112: 154–157PubMedCrossRef
22.
Zurück zum Zitat Gerbasi FR, Bottoms S, Farag A et al. (1990) Increased intravascular coagulation associated with pregnancy. Obstet Gynecol 75: 385–389PubMed Gerbasi FR, Bottoms S, Farag A et al. (1990) Increased intravascular coagulation associated with pregnancy. Obstet Gynecol 75: 385–389PubMed
23.
Zurück zum Zitat Goldszmidt E, Davies S (2003) Two cases of hemorrhage secondary to amniotic fluid embolus managed with uterine artery embolization. Can J Anaesth 50: 917–921PubMedCrossRef Goldszmidt E, Davies S (2003) Two cases of hemorrhage secondary to amniotic fluid embolus managed with uterine artery embolization. Can J Anaesth 50: 917–921PubMedCrossRef
24.
Zurück zum Zitat Green D (2006) The management of acquired haemophilia. Haemophilia [Suppl 5] 12: 32–36 Green D (2006) The management of acquired haemophilia. Haemophilia [Suppl 5] 12: 32–36
25.
Zurück zum Zitat Hansch E, Chitkara U, McAlpine J et al. (1999) Pelvic arterial embolization for control of obstetric hemorrhage: a five-year experience. Am J Obstet Gynecol 180: 1454–1460PubMedCrossRef Hansch E, Chitkara U, McAlpine J et al. (1999) Pelvic arterial embolization for control of obstetric hemorrhage: a five-year experience. Am J Obstet Gynecol 180: 1454–1460PubMedCrossRef
26.
Zurück zum Zitat Hardy JF, Moerloose P de, Samama CM (2006) Massive transfusion and coagulopathy: pathophysiology and implications for clinical management. Can J Anaesth [Suppl 6] 53: S40–S58 Hardy JF, Moerloose P de, Samama CM (2006) Massive transfusion and coagulopathy: pathophysiology and implications for clinical management. Can J Anaesth [Suppl 6] 53: S40–S58
27.
Zurück zum Zitat Hatzopoulos FK (2005) Obstetric drug therapy. In: Koda-Kimble MA, Young LY, Kradjan WA et al. (eds) Applied therapeutics: the clinical use of drugs, 8th edn. Lippincott Williams & Wilkins, Philadelphia, p 126 Hatzopoulos FK (2005) Obstetric drug therapy. In: Koda-Kimble MA, Young LY, Kradjan WA et al. (eds) Applied therapeutics: the clinical use of drugs, 8th edn. Lippincott Williams & Wilkins, Philadelphia, p 126
28.
Zurück zum Zitat Hay CR, Brown S, Collins PW et al. (2006) The diagnosis and management of factor VIII and IX inhibitors: a guideline from the United Kingdom Haemophilia Centre Doctors Organisation. Br J Haematol 133: 591–605PubMedCrossRef Hay CR, Brown S, Collins PW et al. (2006) The diagnosis and management of factor VIII and IX inhibitors: a guideline from the United Kingdom Haemophilia Centre Doctors Organisation. Br J Haematol 133: 591–605PubMedCrossRef
29.
Zurück zum Zitat Heilmann L, Wild C, Hojnacki B et al. (2006) Successful treatment of life-threatening bleeding after cesarean section with recombinant activated factor VII. Clin Appl Thromb Hemost 12: 227–229PubMedCrossRef Heilmann L, Wild C, Hojnacki B et al. (2006) Successful treatment of life-threatening bleeding after cesarean section with recombinant activated factor VII. Clin Appl Thromb Hemost 12: 227–229PubMedCrossRef
30.
Zurück zum Zitat Heindl B, Delorenzo C, Spannagl M (2005) High dose fibrinogen administration for acute therapy of coagulopathy during massive perioperative transfusion. Anaesthesist 54: 787–790PubMedCrossRef Heindl B, Delorenzo C, Spannagl M (2005) High dose fibrinogen administration for acute therapy of coagulopathy during massive perioperative transfusion. Anaesthesist 54: 787–790PubMedCrossRef
31.
Zurück zum Zitat Hellgren M (2003) Hemostasis during normal pregnancy and puerperium. Semin Thromb Hemost 29: 125–130PubMedCrossRef Hellgren M (2003) Hemostasis during normal pregnancy and puerperium. Semin Thromb Hemost 29: 125–130PubMedCrossRef
32.
Zurück zum Zitat Holmes VA (2003) Changes in haemostasis during normal pregnancy: does homocysteine play a role in maintaining homeostasis? Proc Nutr Soc 62: 479–493PubMedCrossRef Holmes VA (2003) Changes in haemostasis during normal pregnancy: does homocysteine play a role in maintaining homeostasis? Proc Nutr Soc 62: 479–493PubMedCrossRef
33.
Zurück zum Zitat Holmes VA, Wallace JM (2005) Haemostasis in normal pregnancy: a balancing act? Biochem Soc Trans 33: 428–432PubMedCrossRef Holmes VA, Wallace JM (2005) Haemostasis in normal pregnancy: a balancing act? Biochem Soc Trans 33: 428–432PubMedCrossRef
34.
Zurück zum Zitat Huch A, Chaoui R (2004) Sectio caesarea: In: SchneiderH, Husslein P, Schneider KTM (Hrsg) Die Geburtshilfe, 2. Aufl. Springer, Berlin Heidelberg New York Huch A, Chaoui R (2004) Sectio caesarea: In: SchneiderH, Husslein P, Schneider KTM (Hrsg) Die Geburtshilfe, 2. Aufl. Springer, Berlin Heidelberg New York
35.
Zurück zum Zitat Kam PC, Thompson SA, Liew AC (2004) Thrombocytopenia in the parturient. Anaesthesia 59: 255–264PubMedCrossRef Kam PC, Thompson SA, Liew AC (2004) Thrombocytopenia in the parturient. Anaesthesia 59: 255–264PubMedCrossRef
36.
Zurück zum Zitat Karalapillai D, Popham P (2007) Recombinant factor VIIa in massive postpartum haemorrhage. Int J Obstet Anesth 16: 29–34PubMedCrossRef Karalapillai D, Popham P (2007) Recombinant factor VIIa in massive postpartum haemorrhage. Int J Obstet Anesth 16: 29–34PubMedCrossRef
37.
Zurück zum Zitat Kobayashi T, Terao T, Maki M et al. (2001) Diagnosis and management of acute obstetrical DIC. Semin Thromb Hemost 27: 161–167PubMedCrossRef Kobayashi T, Terao T, Maki M et al. (2001) Diagnosis and management of acute obstetrical DIC. Semin Thromb Hemost 27: 161–167PubMedCrossRef
38.
Zurück zum Zitat Koscielny J, Tempelhoff GF von, Ziemer S et al. (2004) A practical concept for preoperative management of patients with impaired primary hemostasis. Clin Appl Thromb Hemost 10: 155–166PubMedCrossRef Koscielny J, Tempelhoff GF von, Ziemer S et al. (2004) A practical concept for preoperative management of patients with impaired primary hemostasis. Clin Appl Thromb Hemost 10: 155–166PubMedCrossRef
39.
Zurück zum Zitat Kretzschmar M, Zahm DM, Remmler K et al. (2003) „Anaphylactoid syndrome of pregnancy“ Pathophysiologische und therapeutische Aspekte der Fruchtwasserembolie („anaphylactoid syndrome of pregnancy“) anhand einer Kasuistik mit letalem Ausgang. Anaesthesist 52: 419–426PubMedCrossRef Kretzschmar M, Zahm DM, Remmler K et al. (2003) „Anaphylactoid syndrome of pregnancy“ Pathophysiologische und therapeutische Aspekte der Fruchtwasserembolie („anaphylactoid syndrome of pregnancy“) anhand einer Kasuistik mit letalem Ausgang. Anaesthesist 52: 419–426PubMedCrossRef
40.
Zurück zum Zitat Krumnikl JJ, Böttiger BW, Strittmatter HJ et al. (2002) Complete recovery after 2 h of cardiopulmonary resuscitation following high-dose prostaglandin treatment for atonic uterine haemorrhage. Acta Anaesthesiol Scand 46: 1168–1170PubMedCrossRef Krumnikl JJ, Böttiger BW, Strittmatter HJ et al. (2002) Complete recovery after 2 h of cardiopulmonary resuscitation following high-dose prostaglandin treatment for atonic uterine haemorrhage. Acta Anaesthesiol Scand 46: 1168–1170PubMedCrossRef
41.
Zurück zum Zitat Ku DH, Arkel YS, Paidas MP et al. (2003) Circulating levels of inflammatory cytokines (IL-1 beta and TNF-alpha), resistance to activated protein C, thrombin and fibrin generation in uncomplicated pregnancies. Thromb Haemost 90: 1074–1079PubMed Ku DH, Arkel YS, Paidas MP et al. (2003) Circulating levels of inflammatory cytokines (IL-1 beta and TNF-alpha), resistance to activated protein C, thrombin and fibrin generation in uncomplicated pregnancies. Thromb Haemost 90: 1074–1079PubMed
42.
Zurück zum Zitat Letsky EA (2001) Disseminated intravascular coagulation. Best Pract Res Clin Obstet Gynaecol 15: 623–644PubMedCrossRef Letsky EA (2001) Disseminated intravascular coagulation. Best Pract Res Clin Obstet Gynaecol 15: 623–644PubMedCrossRef
43.
Zurück zum Zitat Lindoff C, Rybo G, Astedt B (1993) Treatment with tranexamic acid during pregnancy, and the risk of thrombo-embolic complications. Thromb Haemost 70: 238–240PubMed Lindoff C, Rybo G, Astedt B (1993) Treatment with tranexamic acid during pregnancy, and the risk of thrombo-embolic complications. Thromb Haemost 70: 238–240PubMed
44.
Zurück zum Zitat Lockwood CJ (2006) Pregnancy-associated changes in the hemostatic system. Clin Obstet Gynecol 49: 836–843PubMedCrossRef Lockwood CJ (2006) Pregnancy-associated changes in the hemostatic system. Clin Obstet Gynecol 49: 836–843PubMedCrossRef
45.
Zurück zum Zitat Ojala K, Perala J, Kariniemi J et al. (2005) Arterial embolization and prophylactic catheterization for the treatment for severe obstetric hemorrhage. Acta Obstet Gynecol Scand 84: 1075–1080PubMedCrossRef Ojala K, Perala J, Kariniemi J et al. (2005) Arterial embolization and prophylactic catheterization for the treatment for severe obstetric hemorrhage. Acta Obstet Gynecol Scand 84: 1075–1080PubMedCrossRef
46.
Zurück zum Zitat Orlikowski CEP, Rocke DA, Murray WB et al. (1996) Thromboelastography changes in pre-eclampsia and eclampsia. Br J Anaesth 77: 157–161PubMed Orlikowski CEP, Rocke DA, Murray WB et al. (1996) Thromboelastography changes in pre-eclampsia and eclampsia. Br J Anaesth 77: 157–161PubMed
47.
Zurück zum Zitat Parnas M, Sheiner E, Shoham-Vardi I et al. (2006) Moderate to severe thrombocytopenia during pregnancy. Eur J Obstet Gynecol Reprod Biol 128: 163–168PubMedCrossRef Parnas M, Sheiner E, Shoham-Vardi I et al. (2006) Moderate to severe thrombocytopenia during pregnancy. Eur J Obstet Gynecol Reprod Biol 128: 163–168PubMedCrossRef
48.
Zurück zum Zitat Pelage J-P, Le Dref O, Jacob D et al. (1999) Selective arterial embolization of the uterine arteries in the management of intractable post-partum hemorrhage. Acta Obstet Gynecol Scand 78: 698–703PubMedCrossRef Pelage J-P, Le Dref O, Jacob D et al. (1999) Selective arterial embolization of the uterine arteries in the management of intractable post-partum hemorrhage. Acta Obstet Gynecol Scand 78: 698–703PubMedCrossRef
49.
Zurück zum Zitat Pfanner G, Kilgert K (2006) Geburtshilfliche Blutungskomplikationen. Hämostaseologie [Suppl 1] 26: S56–S63 Pfanner G, Kilgert K (2006) Geburtshilfliche Blutungskomplikationen. Hämostaseologie [Suppl 1] 26: S56–S63
50.
Zurück zum Zitat Poe MF (1959) Clot observation test for clinical diagnosis of clotting defects. Anesthesiology 20: 825–829PubMedCrossRef Poe MF (1959) Clot observation test for clinical diagnosis of clotting defects. Anesthesiology 20: 825–829PubMedCrossRef
51.
Zurück zum Zitat Prabu P, Parapia LA (2006) Bernard-Soulier syndrome in pregnancy. Clin Lab Haematol 28: 198–201PubMedCrossRef Prabu P, Parapia LA (2006) Bernard-Soulier syndrome in pregnancy. Clin Lab Haematol 28: 198–201PubMedCrossRef
52.
Zurück zum Zitat Ramanathan J, Bennett K (2003) Pre-eclampsia: fluids, drugs, and anesthetic management. Anesthesiol Clin North Am 21: 145–163CrossRef Ramanathan J, Bennett K (2003) Pre-eclampsia: fluids, drugs, and anesthetic management. Anesthesiol Clin North Am 21: 145–163CrossRef
53.
54.
Zurück zum Zitat Roberts HR, Monroe DM, Oliver JA et al. (1998) Newer concepts of blood coagulation. Haemophilia 4: 331–334PubMedCrossRef Roberts HR, Monroe DM, Oliver JA et al. (1998) Newer concepts of blood coagulation. Haemophilia 4: 331–334PubMedCrossRef
55.
Zurück zum Zitat Rouse DJ, MacPherson C, Landon M et al. (2006) Blood transfusion and cesarean delivery. Obstet Gynecol 108: 891–897PubMedCrossRef Rouse DJ, MacPherson C, Landon M et al. (2006) Blood transfusion and cesarean delivery. Obstet Gynecol 108: 891–897PubMedCrossRef
56.
Zurück zum Zitat Schuurmans N, Mackinnin C, Lane C et al. (2000) Prevention and management of postpartum haemorrhage. J Soc Obstet Gynaecol Can 88: 271–281 Schuurmans N, Mackinnin C, Lane C et al. (2000) Prevention and management of postpartum haemorrhage. J Soc Obstet Gynaecol Can 88: 271–281
57.
Zurück zum Zitat Segal S, Shemesh IY, Blumenthal R et al. (2003) Treatment of obstetric hemorrhage with recombinant activated factor VII (rFVIIa). Arch Gynecol Obstet 268: 266–267PubMedCrossRef Segal S, Shemesh IY, Blumenthal R et al. (2003) Treatment of obstetric hemorrhage with recombinant activated factor VII (rFVIIa). Arch Gynecol Obstet 268: 266–267PubMedCrossRef
58.
Zurück zum Zitat Shafi T, Jeha MT, Black L et al. (1997) Severe aquired haemophilia A treated with recombinant factor VIIa. Br J Haematol 98: 910–912PubMedCrossRef Shafi T, Jeha MT, Black L et al. (1997) Severe aquired haemophilia A treated with recombinant factor VIIa. Br J Haematol 98: 910–912PubMedCrossRef
59.
Zurück zum Zitat Sharma SK, Philip J, Whitten CW et al. (1999) Assessment of changes in coagulation in parturients with pre-eclampsia using thromboelastography. Anesthesiology 90: 3485–3490CrossRef Sharma SK, Philip J, Whitten CW et al. (1999) Assessment of changes in coagulation in parturients with pre-eclampsia using thromboelastography. Anesthesiology 90: 3485–3490CrossRef
60.
Zurück zum Zitat Silliman CC, Curtis BR, Kopko PM et al. (2007) Donor antibodies to HNA-3a implicated in TRALI reactions prime neutrophils and cause PMN-mediated damage to human pulmonary microvascular endothelial cells in a two-event in vitro model. Blood 109: 1752–1755PubMedCrossRef Silliman CC, Curtis BR, Kopko PM et al. (2007) Donor antibodies to HNA-3a implicated in TRALI reactions prime neutrophils and cause PMN-mediated damage to human pulmonary microvascular endothelial cells in a two-event in vitro model. Blood 109: 1752–1755PubMedCrossRef
61.
Zurück zum Zitat Smith JG, Merrill DC (2006) Oxytocin for induction of labor. Clin Obstet Gynecol 49: 594–608PubMedCrossRef Smith JG, Merrill DC (2006) Oxytocin for induction of labor. Clin Obstet Gynecol 49: 594–608PubMedCrossRef
62.
Zurück zum Zitat Sobieszczyk S, Breborowicz GH, Platicanov V et al. (2006) Recombinant factor VIIa in the management of postpartum bleeds: an audit of clinical use. Acta Obstet Gynecol Scand 85: 1239–1247PubMedCrossRef Sobieszczyk S, Breborowicz GH, Platicanov V et al. (2006) Recombinant factor VIIa in the management of postpartum bleeds: an audit of clinical use. Acta Obstet Gynecol Scand 85: 1239–1247PubMedCrossRef
63.
Zurück zum Zitat Toy P, Popovsky MA, Abraham E et al. (2005) Transfusion-related acute lung injury: definition and review. Crit Care Med 33: 721–726PubMedCrossRef Toy P, Popovsky MA, Abraham E et al. (2005) Transfusion-related acute lung injury: definition and review. Crit Care Med 33: 721–726PubMedCrossRef
64.
Zurück zum Zitat UNFPA (2003) Maternal mortality update 2002: a focus on emergency obstetric care. United Nations Population Fund, New York UNFPA (2003) Maternal mortality update 2002: a focus on emergency obstetric care. United Nations Population Fund, New York
65.
Zurück zum Zitat Vincent J-L, Rossaint R, Riou B et al. (2006) Recommendations on the use of recombinant activated factor VII as an adjunctive treatment for massive bleeding: a European perspective. Crit Care 10: 1–12CrossRef Vincent J-L, Rossaint R, Riou B et al. (2006) Recommendations on the use of recombinant activated factor VII as an adjunctive treatment for massive bleeding: a European perspective. Crit Care 10: 1–12CrossRef
66.
Zurück zum Zitat Weiner CP (1986) The obstetric patient and disseminated intravascular coagulation. Clin Perinatol 13: 705–717PubMed Weiner CP (1986) The obstetric patient and disseminated intravascular coagulation. Clin Perinatol 13: 705–717PubMed
67.
Zurück zum Zitat Whitta RK, Cox DJ, Mallett SV (1995) Thrombelastography reveals two causes of haemorrhage in HELLP syndrome. Br J Anaesth 74: 464–468PubMedCrossRef Whitta RK, Cox DJ, Mallett SV (1995) Thrombelastography reveals two causes of haemorrhage in HELLP syndrome. Br J Anaesth 74: 464–468PubMedCrossRef
68.
Zurück zum Zitat Xenakis EM, Piper JM (1997) Chemotherapeutic induction of labour. A rational approach. Drugs 54: 61–68PubMed Xenakis EM, Piper JM (1997) Chemotherapeutic induction of labour. A rational approach. Drugs 54: 61–68PubMed
69.
Zurück zum Zitat Yang J, Savitz DA, Dole N et al. (2005) Predictors of vaginal bleeding during the first two trimesters of pregnancy. Paediatr Perinat Epidemiol 19: 276–283PubMedCrossRef Yang J, Savitz DA, Dole N et al. (2005) Predictors of vaginal bleeding during the first two trimesters of pregnancy. Paediatr Perinat Epidemiol 19: 276–283PubMedCrossRef
70.
Zurück zum Zitat Zelop CM, Harlow BL, Frigoletto FD (1993) Emergency peripartum hysterectomy. Am J Obstet Gynecol 168: 1443–1448PubMed Zelop CM, Harlow BL, Frigoletto FD (1993) Emergency peripartum hysterectomy. Am J Obstet Gynecol 168: 1443–1448PubMed
Metadaten
Titel
Blutungen während der Schwangerschaft
verfasst von
Dr. S. Hofer
R. Schreckenberger
B. Heindl
K. Görlinger
H. Lier
H. Maul
E. Martin
M.A. Weigand
Publikationsdatum
01.10.2007
Verlag
Springer-Verlag
Erschienen in
Die Anaesthesiologie / Ausgabe 10/2007
Print ISSN: 2731-6858
Elektronische ISSN: 2731-6866
DOI
https://doi.org/10.1007/s00101-007-1261-2

Weitere Artikel der Ausgabe 10/2007

Der Anaesthesist 10/2007 Zur Ausgabe

Delir bei kritisch Kranken – Antipsychotika versus Placebo

16.05.2024 Delir Nachrichten

Um die Langzeitfolgen eines Delirs bei kritisch Kranken zu mildern, wird vielerorts auf eine Akuttherapie mit Antipsychotika gesetzt. Eine US-amerikanische Forschungsgruppe äußert jetzt erhebliche Vorbehalte gegen dieses Vorgehen. Denn es gibt neue Daten zum Langzeiteffekt von Haloperidol bzw. Ziprasidon versus Placebo.

Eingreifen von Umstehenden rettet vor Erstickungstod

15.05.2024 Fremdkörperaspiration Nachrichten

Wer sich an einem Essensrest verschluckt und um Luft ringt, benötigt vor allem rasche Hilfe. Dass Umstehende nur in jedem zweiten Erstickungsnotfall bereit waren, diese zu leisten, ist das ernüchternde Ergebnis einer Beobachtungsstudie aus Japan. Doch es gibt auch eine gute Nachricht.

Darf man die Behandlung eines Neonazis ablehnen?

08.05.2024 Gesellschaft Nachrichten

In einer Leseranfrage in der Zeitschrift Journal of the American Academy of Dermatology möchte ein anonymer Dermatologe bzw. eine anonyme Dermatologin wissen, ob er oder sie einen Patienten behandeln muss, der eine rassistische Tätowierung trägt.

Ein Drittel der jungen Ärztinnen und Ärzte erwägt abzuwandern

07.05.2024 Klinik aktuell Nachrichten

Extreme Arbeitsverdichtung und kaum Supervision: Dr. Andrea Martini, Sprecherin des Bündnisses Junge Ärztinnen und Ärzte (BJÄ) über den Frust des ärztlichen Nachwuchses und die Vorteile des Rucksack-Modells.

Update AINS

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.